AISAP Cardio vs Salix Coronary Plaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AISAP Cardio

by Aisap

Salix Coronary Plaque

by Artrya Limited

AI Verdict

AISAP Cardio focuses on AI-powered interpretation of medical ultrasound for early cardiac disease detection, including valvular pathologies and functional measurements. Salix Coronary Plaque, conversely, specializes in AI-enabled CCTA analysis for the detection and quantification of coronary plaque and stenosis. While both are cardiology AI tools, their distinct imaging modalities and specific diagnostic targets make them adjacent rather than direct competitors.

Choose AISAP Cardio if…

Choose AISAP Cardio if your primary need is AI-powered assistance for interpreting cardiac ultrasound studies at the point of care. This tool is ideal for clinicians seeking automated analysis, comprehensive measurements of cardiac structures and function (like LVEF and chamber dimensions), and detailed assessment of valvular pathologies directly from ultrasound images.

View AISAP Cardio →

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if your focus is on advanced AI-enabled analysis of Coronary CT Angiography (CCTA) scans to characterize coronary artery disease. This solution is best suited for identifying, quantifying, and assessing the risk features of atherosclerotic plaque, providing critical insights into stenosis and calcium scoring for patient management.

View Salix Coronary Plaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AISAP Cardio	Salix Coronary Plaque
Pricing	Not publicly available	Contact for pricing
Deployment	Cloud-based SaaS platform	Cloud
FDA Status	1 AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AISAP Cardio	Salix Coronary Plaque
Name	AISAP Cardio	Salix Coronary Plaque
Company	Aisap	Artrya Limited
Description	FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside.	FDA-cleared, AI-driven, web-based software that provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease.
Primary Modality	Point-of-Care Ultrasound (POCUS)	CCTA scans
Key Features (Cardiac Assessment)	AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports, assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), measurement of Left Ventricle Ejection Fraction (LVEF), measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter.	AI-enabled CCTA analysis, near real-time, point-of-care assessment, detection and quantification of coronary plaque (atherosclerosis), identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), stenosis assessment, quantification of calcifications (calcium scoring).

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and Salix Coronary Plaque.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary diagnostic focus and imaging modality supported by each tool?

AISAP Cardio primarily focuses on AI-powered interpretation for point-of-care cardiac ultrasound, assisting in the early detection of cardiac diseases, including valvular pathologies and measurements of heart chamber dimensions. Salix Coronary Plaque, on the other hand, specializes in AI-enabled CCTA analysis for the detection and quantification of coronary plaque and stenosis, aiming to change how coronary artery disease is assessed.

What specific cardiac conditions or measurements does each AI tool assist with?

AISAP Cardio provides automated analyses, interpretations, and reports for valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Left Ventricle Ejection Fraction (LVEF), and various ventricular and atrial dimensions. Salix Coronary Plaque offers detection and quantification of coronary plaque, identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification), stenosis assessment, and quantification of calcifications (calcium scoring) from CCTA scans.

What are the key differences in the types of reports generated by each tool?

AISAP Cardio automatically generates comprehensive analyses, interpretations, and reports as part of its cardiac ultrasound software package. Salix Coronary Plaque also provides automated report generation, with the added feature of being editable, for its CCTA analysis.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform